Holmes  Kalen net worth and biography

Holmes Kalen Biography and Net Worth

Director of 1Life Healthcare
Kalen F. Holmes, Ph.D., has served as a member of our board of directors since January 2017. From November 2009 to February 2013, Ms. Holmes served as Executive Vice President of Partner Resources at Starbucks Corporation, a publicly traded retail beverage company. Since December 2014 and August 2016, Ms. Holmes has served on the boards of directors of Zumiez Inc., a publicly traded clothing store, and Red Robin Gourmet Burgers, Inc., a publicly traded restaurant company, respectively. Ms. Holmes earned a B.A. in Psychology from the University of Texas and an M.A. and Ph.D. in Industrial and Organizational Psychology from the University of Houston. We believe that Ms. Holmes is qualified to serve as a member of our board of directors because of her public company management and board experience.

What is Holmes Kalen's net worth?

The estimated net worth of Holmes Kalen is at least $247,939.38 as of June 15th, 2021. Dr. Kalen owns 15,054 shares of 1Life Healthcare stock worth more than $247,939 as of March 27th. This net worth evaluation does not reflect any other investments that Dr. Kalen may own. Learn More about Holmes Kalen's net worth.

How do I contact Holmes Kalen?

The corporate mailing address for Dr. Kalen and other 1Life Healthcare executives is One Embarcadero Center Suite 1900, San Francisco CA, 94111. 1Life Healthcare can also be reached via phone at 415-814-0927 and via email at [email protected]. Learn More on Holmes Kalen's contact information.

Has Holmes Kalen been buying or selling shares of 1Life Healthcare?

Holmes Kalen has not been actively trading shares of 1Life Healthcare during the last ninety days. Most recently, Holmes Kalen sold 31,915 shares of the business's stock in a transaction on Tuesday, January 12th. The shares were sold at an average price of $40.35, for a transaction totalling $1,287,770.25. Following the completion of the sale, the director now directly owns 5,201 shares of the company's stock, valued at $209,860.35. Learn More on Holmes Kalen's trading history.

Who are 1Life Healthcare's active insiders?

1Life Healthcare's insider roster includes Andrew Diamond (Insider), Holmes Kalen (Director), David Kennedy (Director), Kimber Lockhart (CTO), Lisa Mango (General Counsel), Amir Rubin (CEO), and Bjorn Thaler (CFO). Learn More on 1Life Healthcare's active insiders.

Holmes Kalen Insider Trading History at 1Life Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2021Sell31,915$40.35$1,287,770.255,201View SEC Filing Icon  
See Full Table

Holmes Kalen Buying and Selling Activity at 1Life Healthcare

This chart shows Holmes Kalen's buying and selling at 1Life Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

1Life Healthcare Company Overview

1Life Healthcare logo
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $16.47
Low: $16.47
High: $16.47

50 Day Range

MA: $16.09
Low: $14.97
High: $16.57

2 Week Range

Now: $16.47
Low: $5.94
High: $17.55

Volume

523,503 shs

Average Volume

3,216,415 shs

Market Capitalization

$3.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99